Qihui Chu
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 1
-
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 2
- Co-authors
- Weiwei Mu (6 shared papers)Na Zhang (6 shared papers)Yongjun Liu (4 shared papers)Tong Gao (5 shared papers)Yuxiao Fang (5 shared papers)Zipeng Zhang (5 shared papers)Shuang Liang (4 shared papers)Shunli Fu (4 shared papers)
- Journals
- International Journal of Nanomedicine (1 paper)Journal of Controlled Release (1 paper)Frontiers in Endocrinology (1 paper)ACS Nano (1 paper)Nano-Micro Letters (1 paper)
- Partner nations
- China
In The Last Decade
Qihui Chu
7 papers receiving 362 citations
Peers
Comparison fields: 5 of 62
- Biomaterials 146
- Immunology 96
- Biomedical Engineering 194
- Pharmaceutical Science 19
- Oncology 80
Countries citing papers authored by Qihui Chu
This map shows the geographic impact of Qihui Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qihui Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qihui Chu more than expected).
Fields of papers citing papers by Qihui Chu
This network shows the impact of papers produced by Qihui Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qihui Chu. The network helps show where Qihui Chu may publish in the future.
Co-authors
The 18 scholars most cited alongside Qihui Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 255 | |
| 2 | 2021 | 37 | |
| 3 | 2021 | 32 | |
| 4 | 2022 | 15 | |
| 5 | 2022 | 15 | |
| 6 | 2021 | 9 | |
| 7 | 2025 | 2 |
About Qihui Chu
Qihui Chu is a scholar working on Oncology, Immunology, Biomedical Engineering, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine, having authored 7 papers that have together received 365 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Nanoplatforms for cancer theranostics (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune Cell Function and Interaction (2 papers), Microfluidic and Bio-sensing Technologies (1 paper), Cancer Genomics and Diagnostics (1 paper), CAR-T cell therapy research (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Biomaterials (146 citations), Immunology (96 citations), Biomedical Engineering (194 citations), Pharmaceutical Science (19 citations) and Oncology (80 citations). Qihui Chu has collaborated with scholars based in China. Frequent co-authors include Weiwei Mu, Na Zhang, Yongjun Liu, Tong Gao, Yuxiao Fang, Zipeng Zhang, Shuang Liang, Shunli Fu, Li Guan and Dandan Jiang. Their work appears in journals such as International Journal of Nanomedicine, Journal of Controlled Release, Frontiers in Endocrinology, ACS Nano and Nano-Micro Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.